Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.

Recruiting now

Conditions studied: Amyotrophic Lateral Sclerosis

In brief

ActiALS is a multicentric academic study. Patients with amyotrophic lateral sclerosis (ALS) may be included on a voluntary basis. The investigators plan to include a group of approximately 30 patients with ALS. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.

Key facts

Study ID: NCT06228001
Run by: Centre Hospitalier Universitaire de Liege
People needed: 30
Starts: 2023-05-01
Expected to finish: 2028-01-01
Last updated by the study team: 2025-05-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Clinically defined or probable diagnosis of ALS according to El Escorial criteria revised with Awaji's electro-diagnostic algorithm.
Over 18 years old.
Signed informed consent
If patient on Riluzole, the dosage should be stable for 1 month and continued throughout the study period.

You may not qualify if…

Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.
Any other previous or present pathology having an impact on motor function.
Recent surgery or trauma (less than 6 months) in the upper or lower limbs.
Prior neurological, endocrine, infectious, allergic, or chronic or acute inflammatory pathology in the three weeks preceding inclusion.
Patients participating in an interventional clinical trial.

Where it is running

Katholieke Universiteit Leuven — Leuven, Belgium (enrolling)
Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle — Liège, Belgium (enrolling)
Galaa Military Medical Complex — Cairo, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.